cbd podcast

December 15, 2021 By admin Off

See acast.com/privacy for privacy and opt-out information.

Joining us this week, journalist Kate Carter discusses all things CBD and running. Is this cannabis derivative safe? Will you get addicted? Will it cure all your ills and make you a better runner? We try and answers these questions alongside many other things. Also, Jane is back.

Joining us this week, journalist Kate Carter discusses all things CBD and running. Is this cannabis derivative safe? Will you get addicted? Will it cure all your ills and make you a better runner? We try and answers these questions alongside many other things. Also, Jane is back.

These things all make a difference and you know for what it’s worth, it also makes a difference how these things are purportedly reported to you, right? So, when you hear someone say, look we know cannabis is actually good for absolutely everything.

Well, then it’s a very big problem about two hours and 15 minutes later when they’re pretty high. So, all these factors make it an incredibly important group to study, and that’s why we’ve invested so much in looking at our older adults.

And I’m just going to say it right off the bat, the brain is a really complicated organ, so much so that we’ve been studying it for what feels like forever, and yet we still have so much to learn about it.

Relevant Content.

So, all of these things are important. Again, the route of administration is important too, it has very, very low bioavailability when you consume it, when you just swallow it. So, the actual amount that gets quote “in” to do its job is lower.

And the potential liabilities of “addiction” or having what I would call a misuse, or what is really more often termed according to DSM-5 as cannabis use disorder. Is it possible to develop cannabis use disorder?

Jenn: So, I imagine that prior to increased legalization it was really difficult to start performing studies that were related to THC and CBD. Is that changing as the legalization is increasing at state levels, or do you find that you’re still encountering pretty big federal challenges?

I mean, I know it’s a shock, but in a place that has the greatest density of colleges and universities in the world, probably, we don’t have difficulty getting folks in who are interested in being part of those studies.

We don’t see anything, in terms of impairment really in these folks. But do we want to be mindful about what exposure there may be, especially for the most vulnerable in the household? Absolutely, so I think oversight and being clear, facilitating an open and honest dialogue is really your very, very best approach here I think.

That to me is a low dose, that to me. I’m conservative, you can always add, you can never take it away, once it’s in, it’s in. So just remember that, but low dose, I tend to think of lower doses as less than two milligrams, sort of.

Again, the question is when you look at somebody with a first degree relative or a family history of psychotic disorders, or who themselves have had a history of psychotic disorders who turned to cannabis to feel relaxed or take the edge off, where is that fine line between using to some clinical benefit and then tipping the scales and making things significantly worse, and actually creating a psychotic episode?

Episode Transcript.

So, when we think about the constituents and their effects and what they may mean for us, Delta 9 THC again, is often used for people to change their current state of being. And we often hear stories about individuals who are exposed to cannabis because they’re looking to take the edge off, to feel a little bit more relaxed or calm.

Many of the clinical researchers and even preclinical researchers are basically taking their lead from patients who try cannabis or cannabinoids for something, and then we go oh, great, maybe we should try that, we should see if it works. That’s how we design studies, it’s exactly the opposite.

And does it make a difference, so there’s a fairly concerted effort in that area with regard to children, adolescents. There’s a whole program dedicated to it actually in New York state, very, very important. But other than that, I’m thinking about other indications and conditions, I think kids with chronic pain.

Again, these things are tested, if they’re sold in a dispensary they have to be tested by law. And you can ask for a certificate of analysis. If you know about how much you’ve gotten and you know about how much your, let’s say you’re smoking from a bowl, you can sort of guesstimate how much THC, CBD, all the other constituents are in that bowl, and go from there.

So how are we supposed to know what products are right for us and for the conditions that we have? And how can we tell when to separate a quality brand from kind of a snake oil salesman?

So, I think people use it for lots of different things. I don’t know that we have enough at this point to say that it is absolutely clearly helpful for this particular indication or that indication with regards to psychiatry. I think most people are more concerned with the potential detrimental effects of being exposed, especially given the proliferation of high THC products on the market.

Jenn: Hey everyone, welcome to Mindful Things.

Even at my level, it’s expensive, but it’s important because you’re going to put it in your body. And if you’re going to use it for health and wellness or to treat a symptom or condition, as most of our folks do, it’s important to know what it is and what it isn’t.

We actually have a study funded by NIDA to look at the impact of cannabis use in older adults with chronic pain who decide to use or to add medical cannabis to their regimen, versus those who don’t. The reason it’s so important to look at older adults, older adults are the fastest growing consumer group of cannabis users in the country. So, whosever asked this question, kudos to you, thank you, I feel like I owe you a check.

Jenn talks to Staci Gruber, PhD, about myths and misconceptions of marijuana. Dr. Gruber discusses the newest research on cannabis, shares insights on the impact of marijuana on mental health, and separates fact from fiction when considering CBD products available to purchase.

And we’ve had scenarios where we recruit folks and we recruit them into the control group because they’re not cannabis using, and then within 30 seconds, I say, so have you ever tried it? Well, I mean, I don’t use it a lot. Maybe, not that often once, twice a week, not maybe three. Okay, maybe four times. And all of a sudden you know you’re off to the races.

Adriane entered the hemp industry as a parent advocate. At age 3, her son was diagnosed with idiopathic generalized epilepsy. Hundreds of seizures and harmful pharma side effects led Adriane and her husband to search for better options. With the passage of the Federal Farm Bill of 2014, they founded one of the original six companies given authorization to grow and the only company growing for cannabinoid production They began creating quality CBD products for their son and those in need.